Skip to content
Convexia logo

Convexia

Hiring

Convexia is a YC Summer 2025 (S25) company. Team of 4.

About Convexia

GPAgent's own fund-neutral profile, written from public information. Updated Oct 5, 2026.

Summary

Convexia builds an AI-driven drug sourcing and diligence platform for pharma and biotech buyers evaluating preclinical and abandoned drug assets. A pipeline of specialized agents handles discovery, in silico scientific evaluation, commercial analysis, and clinical risk scoring, replacing months of manual work by internal teams or consultants. Human experts, including PhDs and key opinion leaders, validate each stage before a go/no-go decision is made.

Business model

$199/month for asset discovery, $1,497 per generated report, and $2,997/month for a full Pro subscription

Go-to-market

Pharma and biotech teams evaluating drug licensing or acquisition opportunities access the platform self-serve, with a free trial entry point that requires no credit card.

From the Y Combinator listing

How Convexia describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

The world's first AI-maximalist pharma company

An AI-maximalist pharma platform. We use agents to buy drugs, run clinical trials, and sell for a profit. 10x faster and 20x leaner than incumbents. Sourcing Agent: Mines public/private databases and unstructured global data to surface overlooked preclinical candidates. Scientific Agent: Runs comp bio models (ESM-3, RFdiffusion, Boltz-2, AlphaFold) to assess safety and efficacy in silico. Commercial Agent: Analyzes FDA incentives, pricing dynamics, TAM, competitive landscape, and payer alignment. Clinical Agent: Runs digital twin simulations, evaluates CRO/CMC risk, and builds trial plans to Phase 1. PoS Agent: Evaluates the most critical factors that impact the likelihood of clinical trial success. Built by 2 Stanford CS students who have built 3 startups together before.

Facts

Industry
Healthcare / Healthcare -> Drug Discovery and Delivery
Team size
4
Status
Active
Stage
Early

Founders (2)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works